Liquid biopsy for cartilage tumor patients
Part of Cancer clinical trials.
This study looks at whether a simple blood test can help monitor cartilage tumors (chondrosarcoma) and guide treatment. It may offer a less invasive way to track the disease compared to repeated imaging or biopsies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a low-grade or high-grade cartilage tumor (chondrosarcoma).
- You have already had surgery to remove the primary tumor.
- You have not received any previous cancer treatment for this tumor, aside from a diagnostic biopsy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at different types of cartilage tumors to find better ways to diagnose and treat them. If you have a confirmed cartilage tumor, you may be able to join and help researchers learn more about your condition.
This study uses a simple blood test (liquid biopsy) to look for tiny pieces of tumor DNA in people with sarcoma. It may help doctors learn more about the disease and guide treatment decisions, whether you are just diagnosed, being treated, or have finished treatment recently.
This study checks if a blood test can detect DNA from soft tissue sarcomas. The goal is to see if circulating tumor DNA can help doctors monitor the disease and plan treatment.
This study looks at lab biomarkers (signs in tumor tissue) in people with localized leiomyosarcoma. It also requires treatment with chemotherapy before surgery to see if the information from tumor samples can help guide care.
This trial looks at lab markers (biomarkers) in tumor samples from people with leiomyosarcoma that has spread or can’t be fully removed. It also enrolls people who are receiving certain first-line chemotherapy, and your results may help guide future treatment decisions.
This study is testing a new blood test that looks for circulating tumor cells in your blood. The goal is to see if this test can help doctors make better treatment decisions for soft tissue sarcoma, potentially improving how the disease is managed.
Hear when a new Chondrosarcoma of the Bone trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.